NAPSA and neoplasm: The reported sensitivity and specificity of immunohistochemical labeling for napsin A and TTF-1 for supporting the diagnosis of primary lung adenocarcinoma are controversial due to difference in case number (155 vs. 1674 cases), and tumor area (tissue block vs, tissue microarray) [6,7].